1-3 of 3
Noga Or Geva, PhD
Close
Sort by
Journal Articles

Transplantation of T Cell Depleted Haploidentical HSCT Following Non-Myeloablative (NMA) Conditioning: Combining the Power of Megadose Transplants with Post Transplant Cyclophosphamide (PTCY)

Franco Aversa, MD, Esther BacharLustig, PhD, Lucia Prezioso, MD PhD, Sabrina Bonomini, MSc, Noga Or Geva, PhD, Alessandro Monti, MD, Ilenia Manfra, MD, Chiara Schifano, MSc, Federica Galaverna, MD, Yael Zlotnikov Klionsky, PhD, Yair Reisner, PhD
Journal: Blood
Blood (2016) 128 (22): 5765.
https://doi.org/10.1182/blood.V128.22.5765.5765
Published: 2016
Journal Articles

Towards 'Off-the-Shelf ' Universal Chimeric Antigen Receptor (CAR) T Cells: Mouse Anti-3 rd Party Central Memory CD8 Veto Cells Prolong Functional Engraftment of Allogeneic Genetically Modified T Cells

Noga Or Geva, PhD, Rotem Gidron, MD, Aloukick Kumar Singh, PhD, Rakefet Sidlik Muskatel, MD, Yair Reisner, PhD
Journal: Blood
Blood (2016) 128 (22): 2171.
https://doi.org/10.1182/blood.V128.22.2171.2171
Published: 2016
Journal Articles

Next Generation Veto Cells for Non-Myeloablative Haploidentical HSCT: Combining Anti-Viral and Graft Facilitating Activity

Esther Bachar Lustig, PhD, Noga Or Geva, PhD, Assaf Lask, PhD, Rotem Gidron, MD, Sivan Kagan, PhD, Aloukick Kumar Sinqh, PhD, Yair Reisner, PhD
Journal: Blood
Blood (2016) 128 (22): 3345.
https://doi.org/10.1182/blood.V128.22.3345.3345
Published: 2016